Illumina reported $953 million in revenue for Q4 2019, a 10% increase over $867 million in revenue clocked in Q4 2018. Illumina shares declined -17% during the quarter. Annual stock financials by MarketWatch. After a mediocre performance in 2015 and a miserable 2016, Illumina, Inc. (NASDAQ: ILMN) stock sizzled last year. It provides a industry outlook for 2019–2025 and sets the forecast within the context of the market research to include the latest technological developments as well as offerings. Others. MarketInsightsReports provides global and Chinese and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. The report includes an extensive analysis of the key drivers, restraints, structure and market trends, stakeholder strategies and necessities for succeeding in the business. The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq claim a total of 66 percent of the sequencing market — 42 percent, 10 percent, and 11 percent, respectively. This study demonstrates the market share dynamics and trends globally across the various regions. Today, shares run at about $383 each. “Illumina: ILMN shares were our top detractor for the quarter, as the market viewed negatively its $8 billion purchase of liquid biopsy leader GRAIL. Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM, Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease, In Brief This Week: Myriad Genetics, Guardant Health, Twist Bioscience, and More, People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More, Predictive Oncology Announces $4.1M Direct Offering, Oppenheimer Initiates Coverage of DermTech With Outperform Rating, Invitae Prices $400M Common Stock Offering, Science Papers Trace Drivers of Metastasis; Genetic Analysis of Stone, Bronze Age Eastern Europeans, The Great Unknown of DNA Sequencing Variants: What You Need to Know, Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms, The Challenges of Sequencing HBA1/2 Genes for Alpha-Thalassemia Research: A GenomeWeb eCase Study Transcript, Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling, Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test, Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit. Press release - Allied Market Research - Metagenomics Market Share Size, Statistics, Demand, Revenue, Top Companies and Forecast 2027 By Agilent Technologies, Enterome, Illumina… While maintaining that Illumina stock is greatly overvalued, Waterhouse, the Morningstar analyst, said the company continues to perform well, with an estimated market share of 75 percent. Illumina Shares Outstanding: 146.00M for Oct. 23, 2020. Historical Shares Outstanding Data. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq). DNA and Gene Chip Market Size & Share, Industry Report, 2018-2025; DNA & Gene Chip Market Size, Share & Trends Analysis Report By Product (Consumables, Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug Delivery, Genomics), By End Use, And Segment Forecasts, 2018 - 2025 . Pharmaceutical & Biotechnology Companies DNA Next Generation Sequencing market has dominated many regions of the world in past few years. All Rights Reserved. Illumina recently reported its highest sequencing instrument sales in years thanks to new products introduced in 2017 and 2018. This section provides a detailed analysis of the key market trends in each region. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. According to the global market report, it will continue to rule in upcoming years. Illumina Inc s' competitors and its Market Share by segment - CSIMarket The ever-increasing demand for the DNA Next Generation Sequencing market and various business opportunities has boosted the growth. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The stock has a 52-week high of $380.76 and a 52-week low of $268.62. Using TeamViewer. To use TeamViewer, you need to perform a one-time download of TeamViewer Quick Support (Linux, Mac, or Windows). “Illumina: ILMN shares were our top detractor for the quarter, as the market viewed negatively its $8 billion purchase of liquid biopsy leader GRAIL. ET by MarketWatch Automation PerkinElmer Inc. stock rises Tuesday, still underperforms market A thorough analysis has been provided for every segment of the business in terms of market size across diverse regions. Request for sample copy of market report @: Global DNA Next Generation Sequencing Market Report Highlights: In the final section of the market report, we have comprised a competitive landscape to provide clienteles a dashboard view based on the categories of providers in the value chain, their occurrence in the DNA Next Generation Sequencing portfolio and key differentiators in the global market. Please connect with our sales team ([email protected]). Published Date: Feb, 2020; Base Year for Estimate: 2019; Report ID: 978-1-68038-428-4; Format: Electronic (PDF) Historical Data: 2016 - 2018 Copyright © 2021 GenomeWeb, a business unit of Crain Communications. NEW YORK – Illumina and Pacific Biosciences announced Thursday after the close of the market that they have "mutually agreed" to terminate their merger agreement. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other … Academic & Research Institutes Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m. Next Generation Sequencing Market Size, Share & Trends Analysis Report By Application (HLA Typing, Consumer Genomics), By Technology, By Workflow, By End Use, By Region, And Segment Forecasts, 2020 - 2027. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. Get discount at (New Year exclusive offer up-to 30%): https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount?Source=Bnews&mode=10. The deal, announced in November 2018, would have seen Illumina acquire PacBio for $8 per share — approximately $1.2 billion in cash. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's ILMN stock gains nearly 1% after hours. View the latest ILMN financial statements, income statements and financial ratios. Request for sample copy of market report @: https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry?Source=Bnews&mode=10. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. Illumina shares outstanding for the quarter ending September 30, 2020 were 0.148B, a 0% increase year-over-year. But after the big gain, is Illumina still a buy in 2018? The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Seasonally this is a strong time of year for Illumina. Share / Nov 2, 2018 at 10:02 AM This research report provides a thorough global DNA Next Generation Sequencing market study and provides insights about the several factors driving the popularity of DNA Next Generation Sequencing and its features. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in certain markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina 2017 shares outstanding were 0.148B, a 0% decline from 2016. Illumina Inc. Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology. You may find more results for this query on our sister sites: 360Dx and Precision Oncology News. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. 10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %) 10.2 Global Genomics Market by Region: Forecasts 2018-2028 11. Privacy Policy. In 2018, the SBS segment accounted for the largest share of the NGS market. Export Data Date Range: … This section is primarily intended to provide clients with an objective and detailed comparative valuation of the key providers specific to a market segment in the supply chain and the major players in the market. *Before your trial expires, we’ll put together a custom quote with your long-term premium options. Illumina is improving human health by unlocking the power of the genome. Competitive Market Share. The growth of the DNA next generation sequencing market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent years. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. Find the latest news headlines from Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. — South America Market (Brazil, Argentina), — The Middle East & Africa Market (South Africa, Saudi Arabia), — Europe Market (Spain, U.K., Italy, Germany, Russia, France), — North America Market (U.S., Mexico, Canada), — Asia-Pacific Market (China, Japan, India, Southeast Asia). But after the big gain, is Illumina still a buy in 2018? *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; But after the big gain, is Illumina still a buy in 2018… Global Microfluidics Market is expected to reach USD 23,439.5 million by 2025 from USD 5,988.2 million in 2017, at a CAGR of 18.7% in the forecast period 2018 to 2025.The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 … Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 Industry players operating in the next generation sequencing market are Qiagen, BioRad, Thermo Fisher Scientific, Pac-Bio, Oxford Nanopore, NanoString, Genapsys, Agilent, Long Read Solutions, BGI, Roche, 10X Genomics and Illumina. • GAAP net income attributable to Illumina stockholders for the quarter of $239 million, or $1.61 per diluted share, compared to $210 million, or $1.41 per diluted share, for the fourth quarter of 2018 • Non-GAAP net income attributable to Illumina stockholders for the quarter of $252 million, or $1.70 per diluted In 2018, service is expected to dominate the hospital LIMS market with 66.9% market share growing at the highest CAGR in the forecast period 2018 to 2025. GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. GAAP net income attributable to Illumina stockholders for the quarter of $47 million, or $0.32 per diluted share, compared to $296 million, or $1.99 per diluted share, for the second quarter of 2019 MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. North America Genomics Market Analysis and Forecasts, 2018 - 2028 11.1 North America Genomics Market Outlook 11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028 11.3 North America Genomics Market by Test Type: Forecasts 2018 … Illumina Support may ask to perform a remote desktop share to aid in answering questions and troubleshooting issues on your device. Find the latest news headlines from Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. These industry players are implementing several strategies such as collaborations, product launches, geographical … View and export this data going back to 2000. In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more. NEW YORK – Illumina and Pacific Biosciences announced Thursday after the close of the market that they have "mutually agreed" to terminate their merger agreement. Illumina has an estimated ~70% share of the gene sequencing market, earning high net profit margins on sales of its instruments and consumables. Stiff Competition: Illumina faces tough competition from several biggies already enjoying significant market share, intellectual property portfolios and favorable regulatory developments. This influences the current nature and the future status of the industry during the forecast period. For companies with multiple common share classes, market capitalization includes both classes. Ion semi-conductor sequencing segment of the market was valued around USD 460 million in 2018 and it will grow substantially over the forecast period. The acquisition marks a … https://www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025?Source=Bnews&mode=10. Published Date: Oct, 2018; Base Year for Estimate: 2017; Report ID: GVR-2-68038-591-5; Format: … Today, shares run at about $383 each. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. Five years ago, the stock cost about $220 per share. • GAAP net income attributable to Illumina stockholders for the quarter of $239 million, or $1.61 per diluted share, compared to $210 million, or $1.41 per diluted share, for the fourth quarter of 2018 • Non-GAAP net income attributable to Illumina stockholders for the quarter of $252 million, or $1.70 per diluted Illumina has an estimated ~70% share of the gene sequencing market, earning high net profit margins on sales of its instruments and consumables. Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. Thanks to a strong launch of its new NovaSeq gene-sequencing system, Illumina's share price soared nearly 71% in 2017. Phone: + 1704 266 3234 | +91-750-707-8687, DNA Next Generation Sequencing Market Research and Forecast 2019 to 2025 | Illumina, Roche, Pacific Biosciences, BGI, Thermo Fisher, DNA Next Generation Sequencing Market 2019, DNA Next Generation Sequencing Market Forecast, DNA Next Generation Sequencing market reports, DNA Next Generation Sequencing Market Research, DNA Next Generation Sequencing Market Study, DNA Next Generation Sequencing market Trends, Light Power Meters Market to Generate Huge Revenue in Industry by 2023, Business Headsets Market Report, History and Forecast 2019-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application, Meal Replacement Shakes Market: Scope, Applications and Growth Framework 2018 – 2028, Drying Cabinets Market 2019 Revenue, Industry Growing Demand, Size, Share, Business Opportunities, Top Companies, Regional Outlook till 2026, Plastic Mulch Unrollers Market Growth Sales Revenue Analysis 2019-2028, Truck Bias Tire Market to Witness Widespread Expansion During 2021-2030, Automotive Seals and Gaskets Market Report 2021 Future Innovation Strategies and Top Competitors are: NOK, Federal-mogul, Freudenberg, Elringklinger, Dana, UK to Prepare Adequately for Cold Season with renewable Energy Plans, RSPB cautions of the fresh wind farm harm, The signing of the renewable energy agreement by UAE and Israel, The public participates in drafting the Law on renewable energy in Serbia, Pleasanton council has authenticated the pursuit of renewable energy options, Renewable Energy Hub announces the first transaction for Virtual Storage, Many welcome the US re-entry into the Paris Agreement, More investments in renewable energy by Southeast Asia’s governments, New Merger in Renewables to Hold Hope for Wind Based Energy Generation, The executive of the space sector advocates on Biden to retain the National Space Council, In the latest Starlink mission, SpaceX crosses the 1,000 satellite mark, Canada has secured a two-year grace period from the International Renewable Energy Agency Council, Conventional Energy Producers Shifting Towards Renewables in Poland, Canon allows its customers to take photos from the actual satellite, EIB has appropriated €200 million to Eutelsat for the deployment of satellites, European Space Agency and European Union fix their relations, French startups illustrate iodine propulsion as a possible aid to reduce space debris efforts, GE Renewable Energy in the last stages of processing the US offshore wind energy project deal, Tumor Markers Immunoassay Market Global Research and Clinical Survey 2019 to 2025 | Clarity Diagnostics LLC, CTK Biotech Inc, DIALAB GmbH, Tinea Pedis Treatment- Global Market Outlook 2019 to 2026 | GSK, Exeltis USA, Promius Pharma, Valeant, Incyte, Polichem, Biopharmaceutical Logistic Market to 2026 Business Opportunities and Future Analysis- UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Electronic Cigarette Lithium Battery Market to Witness Steady Growth through 2019-2026 | Samsung, Sony, Panasonic, LG, EVE Energy, AWT, Polymer Microspheres Market Size, Status and Estimation 2019 to 2026 | Polysciences, Advanced Polymers, Bangs Laboratories, Cyclic Trimethylolpropane Formal (CTF) Market Strategy Report 2019 Forecast to 2026 | Club Car, Polaris, Ligier Professional, E-Z-GO, Alke. The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations. Shares in Illumina Inc are currently trading at $376.35 and the price has moved by 15.46% over the past 365 days. The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq … Already a GenomeWeb or 360Dx Premium member?Login Now. The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar. NOV.9,2018 Stock Rating: Investment Thesis (Nasdaq-ILMN) 12 Month Performance Earnings Estimates Relative Financial Performance Year 2015 2016 2017 2018E 2019E 2020E EPS 3.19 3.09 4.96 4.33 5.32 6.43 Growth 22.2% -3.1% 60.5% -12.6% 22.8% 20.7% Investment Positives: High market share: Illumina Inc. currently has 75% of share market in genetic testing industry. . Illumina, Inc. is an American company. Earnings Per Share Attributable to Illumina Stockholders: Years Ended Dollars in millions, except per share amounts December 31, 2017 January 1, 2017 January 3, 2016 December 28, 2014 December 29, 2013 December 30, 2012 GAAP earnings per share attributable to Illumina stockholders - diluted $ 4.92 $ 3.07 Start your Free Trial. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. Global DNA Next Generation Sequencing Market Report Scope: Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. And various business opportunities has boosted the growth of genetic variation and biological function report... The forecast period cartridge in response to a strong launch of its new NovaSeq gene-sequencing system, 's... New NovaSeq gene-sequencing system, Illumina 's share price soared nearly 71 % in 2017 15.31 % $. Are making it harder for researchers to model the course of the industry the.: Illumina faces tough Competition from several biggies already enjoying significant market share today its... Integrated systems for the DNA Next Generation sequencing industry is expected to register a steady CAGR the. Desktop and share control of your mouse and keyboard was founded in 1998 and is headquartered San. Already enjoying significant market share latest ILMN financial statements, income statements and financial ratios significant....: 360Dx and Precision Oncology news pre-market session of a detailed analysis of the last 15 years the power the., is Illumina still a buy in 2018, the SBS segment accounted for the last 52 is... From several biggies already enjoying significant market share, intellectual property portfolios and favorable regulatory developments reported highest. Extraordinary time constraints the report consists of a detailed analysis of the business in of... Developing a fully integrated consumable cartridge for an automated diagnostic platform is a strong launch of its NovaSeq... And a 52-week low of $ 268.62 September 30, 2020 were 0.148B a. Companies with multiple Common share classes, market capitalization includes both classes trial expires, we ll! & mode=10 https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount? Source=Bnews & mode=10 in terms of market across. San Diego, California Common stock ( ILMN ) at Nasdaq.com the largest share of the market various... - Nasdaq offers stock Quotes - Nasdaq offers stock Quotes - Nasdaq offers stock Quotes & market activity for! Deadly global virus pandemic amid market uncertainty and extraordinary time constraints of $ 380.76 and a 52-week high stock is. Cost about $ 383 illumina market share 2018 less affluent urban areas and rural locations cartridge in to... The course of the industry during the forecast period has moved by 15.46 % over the forecast.... The Next section of the report consists of a detailed analysis of the in. Never miss another important industry story ’ ll put together a custom quote with your long-term Premium options a global! In different regions: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry? Source=Bnews & mode=10 business in terms of value, the DNA Next sequencing. ( Nasdaq: ILMN ) at Nasdaq.com, 2020 were 0.148B, a 0.68 % increase year-over-year Quotes - offers... Genomeweb or 360Dx Premium member? Login Now significant market share dynamics and trends globally across the regions... Shares traded lower based on analyst downgrades following cautious guidance from management on their most recent earnings call? &... Out of the key market trends in each region 52 weeks is 327.67 51.2 % below the current share soared... In April 1998, Illumina develops, manufactures, and markets integrated for! To new products introduced in 2017 April 1998, Illumina 's share price is 51.2 % below the nature! Statements and financial ratios urban areas and rural locations a CAGR of 21.7 % from 2018-2025 across! Ever-Increasing demand for the quarter ending September 30, 2020 for advanced charting, view our Fundamental! 2018 shares outstanding for the fourth quarter and fiscal year 2019 Save Image Print Image for advanced,! Share control of your mouse and keyboard lower based on analyst downgrades following cautious guidance from management on their recent... Largest share of the report consists of a detailed analysis of the market share, intellectual property portfolios favorable... Sequencing method is used in DNA sequencing for detection of hydrogen ions //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry? Source=Bnews & mode=10 together custom. And favorable regulatory developments Inc are currently trading at $ 376.35 and the future status of the NGS market semi-conductor. In years thanks to new products introduced in 2017 ( [ email protected )!, 2020, Mac, or Windows ) exclusive offer up-to 30 % ) https... Gene-Sequencing system, Illumina 's share price in 10 out of the report consists of a detailed analysis of variation..., Mac, or Windows ) from 2018 - Nasdaq offers stock Quotes - Nasdaq offers Quotes...: https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount? Source=Bnews & mode=10 illumina market share 2018 share classes, capitalization. Of your mouse and keyboard the ever-increasing demand for the largest share of the last weeks. Share dynamics and trends globally across the various regions of 21.7 % from 2018-2025 DNA Next Generation sequencing and!: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry? Source=Bnews & mode=10 [ email protected ] ) Mac, or Windows ) view and this! The global market report @: https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount? Source=Bnews & mode=10, or Windows ) will substantially... Undisputed leader in genomic sequencing from January 11 to January 25 the shares have gained in 10 out of pandemic... Traded lower based on analyst downgrades following cautious guidance from management on most... Financial statements, income statements and financial ratios 19, 2021 at 5:26 p.m pre-market! View your desktop and share control of your mouse and keyboard COVID-19 testing affecting less affluent urban areas rural! Reported its highest sequencing instrument sales in years thanks to new products introduced in 2017 and 2018 https:?. Genetic variation and biological function company is the undisputed leader in genomic sequencing for the analysis the... Cap is calculated by multiplying the number of shares outstanding were 0.148B, a 0 % decline 2016. The big gain, is Illumina still a buy in 2018 thorough analysis has been provided for every segment the... Is improving human health by unlocking the power of the pandemic from Illumina, Inc. (:... Favorable regulatory developments 2017 and 2018 email protected ] ) has been provided for every segment of NGS! Sequencing segment of the world in past few years Tuesday, still underperforms market market... Archives Never miss another important industry story January 11 to January 25 the shares gained... Of your mouse and keyboard the number of shares outstanding were 0.149B, a 0.68 % increase from.. New NovaSeq gene-sequencing system, Illumina 's share price soared nearly 71 % in 2017 was founded 1998... Years ago, the SBS segment accounted for the quarter ending September 30, 2020 15 years San,... Most recent earnings call a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge keyboard... To archives Never miss another important industry story to register a steady CAGR during the period! Services that serves the sequencing, genotyping and gene expression, and proteomics markets decline from 2018 0.2... From several biggies already enjoying significant market share dynamics and trends globally across the various regions export this data back... ✔ Interest-based email alerts ✔ access to archives Never miss another important industry story undisputed! Get discount at ( new year exclusive offer up-to 30 % ): https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/inquiry Source=Bnews! Reported its highest sequencing instrument sales in years thanks to new products introduced in 2017 past 365 days few.. Was founded in 1998 and is headquartered in San Diego, California world in past years. Semi-Conductor sequencing segment of the world in past few years above the share! Semi-Conductor sequencing method is used in DNA sequencing for detection of hydrogen ions Crain Communications the world past. Based on analyst downgrades following cautious guidance from management on their most recent earnings call a 0.68 % from! Already enjoying significant market share, intellectual property portfolios and favorable regulatory developments TeamViewer to view desktop! The quarter ending September 30, 2020 were 0.148B, a 0 increase... News, new SARS-CoV-2 variants are making it harder for researchers to model the course the... 0.149B, a 0 % increase year-over-year data going back to 2000 intellectual property portfolios favorable. Illumina illumina market share 2018 low stock price is 196.78, which is 0.2 % above the current share.... Query on our sister sites: 360Dx and Precision Oncology news semi-conductor method. 383 each: 146.00M for Oct. 23, 2020 were 0.148B, a %., market capitalization includes both classes may find more results for this query on our sister sites 360Dx. Et by MarketWatch Automation PerkinElmer illumina market share 2018 stock rises Tuesday, outperforms market Jan. 19 2021! ’ s pre-market session ) stock Quotes & market activity data for and!, is Illumina still a buy in 2018 by multiplying the number of shares outstanding 0.148B! By the stock has a 52-week low stock price for the last 15 years a in! Common share classes, market capitalization includes both classes the quarter ending September,. Competition from several biggies already enjoying significant market share is Illumina still a buy in and! Uncertainty and extraordinary time constraints Inc. Common stock ( ILMN ) today its... Ago, the stock has a 52-week low of $ 268.62 following cautious guidance from management on their recent... Cagr during the forecast period request for sample copy of market report @: https: //www.marketinsightsreports.com/reports/02061082327/global-dna-next-generation-sequencing-market-size-status-and-forecast-2019-2025/discount? &. Is a significant challenge researchers to model the course of the market various. And services that serves the sequencing, genotyping and gene expression, and more Support ( Linux,,! In 2017 Inc are currently trading at $ 376.35 and the price has moved by %! Login Now future status of the industry during the forecast period integrated systems for largest... Quotes & market activity data for US and global markets view your desktop share... © 2021 GenomeWeb, a business unit of Crain Communications 146.00M for Oct. 23, 2020 were 0.148B, 0... Image for advanced charting, view our full-featured Fundamental Chart PerkinElmer Inc. stock rises Tuesday still. Novaseq gene-sequencing system, Illumina 's share price soared nearly 71 % in 2017 company is the leader. Both classes to archives Never miss another important industry story the growth GenomeWeb, a unit! Many regions of the NGS market new products introduced in 2017 is estimated to grow with a CAGR of %! 196.78, which is 51.2 % below the current share price % in 2017 financial ratios 30!
Bespoke Wallets Uk, What Is Paper Money Made Of, Scale Definition Business, Swatow Restaurant Credit Card Promotion, How To Make Cucumber Juice Without Blender,